Nusano Announces Formation of Strategic Advisory Board and Appointment of Inaugural Members

West Valley City, Utah – August 7, 2025

Nusano, a physics company transforming the production of radioisotopes, today announced the formation of its Strategic Advisory Board along with the appointment of its first three members. The Board will provide critical guidance as the company brings its breakthrough radioisotope production and mass separation technologies to industrial, commercial, aerospace, and defense markets—including applications such as HALEU nuclear fuel and radioisotope-powered nuclear batteries.

The inaugural members were selected for their extensive leadership experience and proven impact across government affairs, public policy, armed forces, healthcare, and industry. Their expertise will help shape Nusano’s strategic direction as it scales production, expands its customer base, and advances next-generation products.

“We are honored to welcome this distinguished group to Nusano’s Strategic Advisory Board,” said Chris Lowe, CEO of Nusano. “Each member brings deep, sector-specific knowledge that directly aligns with our growth trajectory. Their insights will be instrumental as we expand our technology platform, reinforce domestic supply chains, and drive innovation across critical industries.”

New Board Members

The Honorable Dr. David J. Shulkin
Former U.S. Secretary of Veterans Affairs

Dr. Shulkin served as the ninth Secretary of the U.S. Department of Veterans Affairs under President Trump and as Under Secretary for Health under President Obama—making him the only cabinet official to serve both administrations. A board-certified internist, he led several major hospital systems, including Beth Israel (NYC) and Morristown Medical Center (NJ). He currently serves on the board of Sanford Health and is a vocal advocate for veterans, serving on numerous nonprofit boards.

Corey Johnston
Executive Vice President, Strider Technologies

Mr. Johnston is a leading expert in nation-state risk to technology. At Strider Technologies, he has led efforts to deliver strategic intelligence solutions to industry, government, and academia. His 30-year career in the U.S. Navy included roles as a naval aviator, diplomat, and economic statesman, with postings in Taipei, Beijing, East Africa, and the U.S. Department of State. As Chief Competition Officer under Secretary Michael Pompeo, he played a key role in onshoring semiconductor supply chains and co-authored the CHIPS and Science Act.

Seema Singh Bhan
Former SVP, Public Policy & External Affairs, Thrive Earlier Detection Corp.

Ms. Singh Bhan brings over two decades of experience in government affairs, advocacy, and public policy. She has held senior roles at Thrive (acquired by Exact Sciences) and Foundation Medicine, helping shape policy for breakthrough diagnostic technologies. She previously served as Senior Counsel to the U.S. Senate Judiciary Committee and Senator Arlen Specter. Her work bridges public and private sectors, bringing together regulators, academics, and industry leaders to accelerate scientific innovation.

Nusano’s new advisory board brings deep, cross-sector expertise in government, healthcare, policy, and national security. The company combines proven technologies from top universities and research institutions with its own patented particle acceleration platform—marking the most significant leap in radioisotope production in decades.

As Nusano approaches operational launch and prepares for a formal ribbon-cutting at its new West Valley City facility later this month, the advisory board will play a key role in guiding its expansion into HALEU production. HALEU is essential to powering the next generation of advanced reactors, enabling the efficient and secure domestic production of high-purity isotopes for applications ranging from cancer diagnostics and treatment to energy innovation and national defense.

For more information, visit Nusano's website.